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 INTRODUCTION 
Critical care medicine has remarkably improved in past few decades. 
Newer antibiotics are being introduced daily. Even then, sepsis is one of the 
leading causes of death worldwide. Sepsis related deaths are more common 
in developing nations like India. Epidemiology of sepsis is changing. The 
reasons for this change are infections which were previously fatal are now 
controlled by use of effective antibiotics and immunization. Yet new 
infections are on the rise. Increased utilization of invasive devices and 
technology has led to health care associated infections. Various biochemical 
indicators are used to diagnose, prognosticate and to guide treatment in 
children with septic shock. 
OXYGEN DELIVERY 
The main function of cardio respiratory system is to maintain delivery 
of oxygen and nutrients to the body tissues and remove the end products of 
metabolism. When there is reduced oxygen supply, tissue demands could not 
be met and this results in low central venous oxygen saturation. Anaerobic 
metabolism occurs when there is prolonged tissue hypoxia leading to the 
production of lactic acid. Adequate supply of oxygen to tissues depends on  
1. Adequate oxygen content in the blood. 
2. Cardiac output with sufficient blood flow to organs. 
 3. Adequate blood flow according to local tissue metabolic demand. 
4. Ability to utilize oxygen by the mitochondria  
Oxygen content in blood is determined by the concentration of 
hemoglobin and percentage of hemoglobin that is saturated with oxygen. 
Adequate blood flow to the tissues is determined by cardiac output 
and local tissue demand. Cardiac output is the amount of blood that flows 
through tissues in 1 minute. Cardiac output is determined by stroke volume 
and heart rate. 
Stroke volume is the amount of blood pumped by the heart with each 
beat. Heart rate is the number of contractions by heart each minute. 
 
Oxygen delivery   Oxygen content of blood X cardiac output 
 
 
     
   
SHOCK 
Shock is an acute syndrome characterised by body’s inability to 
deliver adequate oxygen to meet the metabolic demands of vital organs and 
tissues
1
. In shock   there is   insufficient oxygen at the tissue level to support 
Stroke volume X Heart rate 
Preload contractility, after load. 
 normal aerobic cellular metabolism. If inadequate tissue perfusion persists 
adverse vascular, inflammatory, metabolic, cellular, endocrine and systemic 
responses worsen physiological stability. 
Compensation for inadequate oxygen delivery involves various 
responses that attempt to preserve oxygenation to vital organs like brain, 
heart, kidney, liver at the expense of other organs. Untreated shock causes 
irreversible tissue and organ injury ultimately leading to death. The pattern 
of responses, pathophysiology, clinical manifestation and treatment vary 
significantly depending on the specific aetiology, clinical circumstances and 
individual response to the shock states.  
There are 5 types of shock 
 (1) Hypovolemic shock (2) Cardiogenic shock (3) Obstructive shock 
  (4) Distributive shock    (5) Septic shock 
 
HYPOVOLEMIC SHOCK  
This is the most common type of shock in children worldwide. It is 
characterised by decreased preload secondary to internal or external loss. 
Causes include haemorrhage, burns, vomiting and diarrhoea. 
 
 
 CARDIOGENIC SHOCK 
It occurs secondary to poor myocardial function. Causes include 
congenital heart disease, cardiomyopathy, ischemia to myocardium, 
arrhythmias.  
OBSTRUCTIVE SHOCK 
It occurs due to decreased cardiac output secondary to direct 
impediment to outflow or restriction of pumping of all cardiac chambers. 
Aetiologies include tension pneumothorax, pericardial tamponade, 
pulmonary embolism, anterior mediastinal masses and critical coarctation of 
aorta.  
DISTRIBUTIVE SHOCK   
In distributive shock abnormalities of vasomotor tone occur due to 
loss of venous and arterial capacitance leading to maldistribution of fluid. 
Causes include anaphylaxis, loss of sympathetic vascular tone secondary to 
spinal cord or brainstem injury.  
SEPTIC SHOCK 
Sepsis is a clinical syndrome that occurs as a result of severe 
infection. It is characterized by systemic inflammation and widespread tissue 
injury. Septic shock involves complex interaction of distributive, 
hypovolemic and cardiogenic shock. There is third spacing of fluids into the 
 interstitium causing hypovolemia. Inappropriate vasodilatation occurs 
leading to maldistribution. 
HISTORY OF SEPSIS  
The word ‘sepsis’ was first introduced by Hippocrates
2
 (460 - 370 
BC). It was derived from the Greek word ‘Sipsi’ which means “make 
rotten”. Ibn Sina (979 – 1037 BC) found the coincidence of blood 
putrefaction and fever
2
. Ignaz Semmelweis (1818 - 1865), an obstetrician 
gave the modern view of sepsis. He discovered that puerperal fever was 
caused by decomposed animal matter that entered the blood system. He 
demonstrated that, hygienic measures like hand washing before examination 
can reduce the occurrence of puerperal fever. Joseph Lister introduced 
antisepsis. Louis Pasteur, a French chemist discovered tiny single cell 
organisms. He named them as bacteria and said that these microbes could be 
causing disease
2
. Even after many years of discovery, sepsis continues to be 
the major cause of morbidity and mortality. 
EPIDEMIOLOGY  
 According to data from the World Health Organization, United 
Nations Children’s Fund, 70% of Under 5 mortality in children is caused by 
infections
3
. Studies show that more than 40,000 children develop severe 
sepsis each year in United States with an annual incidence of 0.56 cases per 
 1000 population
4
. Many experts say that the incidence of sepsis will 
continue to increase by approximately 1.5 % every year. While above are the  
problems in developed nations, in developing countries other difficulties  
faced include poverty, overcrowding, illiteracy, poor funding  for health 
care. 
PATHOPHYSIOLOGY 
Pathophysiology of septic shock is very complex. It involves a 
cascade of events ranging from bacteremia to sepsis, severe sepsis and septic 
shock. It depends on the specific microorganism, immune status of the host 
and other factors such as presence of indwelling catheter. The first step in 
pathogenesis is the colonization and invasion. Encapsulated organisms like 
Pneumococcus, Hemophilus influenzae (H.influenzae) normally reside in the 
nasopharynx. A preceding viral upper respiratory tract infection causes 
alterations in local host defence mechanism resulting in bacteraemia.  For 
example, cytokines generated during viral infection causes up regulation of 
platelet activating factors on epithelial cells of the respiratory system. 
Pneumococci bind to these receptors and invade subsequently. In case of 
gram negative enteric organism, pili or adhesin helps in attachment to the 
epithelial surface. Similarly, pili are also important in the pathogenesis of 
 some gram positive bacterial infections like Streptococcus pyogenes, Group 
B streptococcus, and Streptococcus pneumoniae.  
Gram negative organisms are responsible for bacteraemia from 
gastrointestinal and genitourinary system. These bacteria cause localized 
abscess or peritonitis leading to bacteraemia. In some children these 
organisms translocate from intestine into blood stream, when the mucosa is 
damaged. The integrity of skin protects against invasion by microorganisms 
like Staphylococcus aureus, Streptococcus which are common inhabitants. 
Any ulcer in skin or presence of foreign material within the skin like 
catheters renders the skin more susceptible to bacterial invasion. 
The endotoxin or Lipopolysaccharide has three basic components  
1. Terminal side chain consisting of repeating oligosaccharides  
These are responsible for the antigenic specificity of ‘O’ antigens 
and are unique to a particular strain 
2. Core lipopolysaccharide 
3. Lipid A – It is similar among different strains. It is responsible for 
biological activity of endotoxin. 
 
 
 
 FIG 1: PATHOGENESIS OF SEPTIC SHOCK 
 
The biological equivalent of endotoxins in gram positive bacteria is 
the peptidoglycan layer as well as non-peptide glycan polymer teichoic acid. 
Some exotoxins of gram positive organisms initiate inflammation. Examples 
include toxic shock syndrome toxin from certain strains of Staphylococcus 
aureus and certain strains of group–A Streptococcus. These toxins act as 
 super antigens that bind to non – conventional binding sites on antigen-
presenting cells and T-cells. This type of attachment permits very small 
amount of toxins to stimulate proliferations of large number of T 
lymphocytes and subsequently large quantities of cytokines. 
The LPS-binding protein is an acute phase protein which helps in 
recognition of endotoxin. This protein binds with LPS and then forms a 
complex with receptor for LPS, CD14 molecule
5,6
. This CD14 is present on 
surface of macrophage. This complex then activates trans membrane 
signaling pathways involving toll-like receptors [TLR- 4 for gram negative 
bacteria; TLR 2 for gram positive bacteria] which in turn causes activation 
of various enzymes. This leads to translocation of nuclear factor KB and 
production of tumor necrosis factor and various inflammatory mediators. 
 FIG 2: PATHOPHYSIOLOGICAL EVENTS OF SEPTIC SHOCK 
 
Endotoxin has a variety of effects 
1. Activation of endothelium  
2. Activation of macrophage 
Endotoxin causes release of endothelium derived relaxing factors or 
nitric oxide which is a potent vasodilator and causes hemodynamic 
disturbance. Coagulation cascade is activated. Both the extrinsic and 
 intrinsic pathways are activated. Tissue factor released from endothelium 
initiates the extrinsic pathway with subsequent activation of factor VII, X 
and thrombin. Interaction of endotoxin with endothelium causes activation 
of factor XII (Hageman factor) which in turn initiates intrinsic clotting 
pathway. In sepsis, levels of Protein – C are decreased. Protein – C has 
antithrombotic and anti-inflammatory properties.  
The lipopolysaccharide activates complement cascade by the classic 
or alternate pathway. Activated factor XII triggers complement system to 
produce C5a, which is a chemotactic stimulus for neutrophils causing 
neutrophil aggregation. These in turn produce reactive oxygen species which 
cause cell injury, lipid peroxidation and DNA strand breaks. LPS or by 
complement system, activate phospholipase enzymes resulting in release of 
arachidonic acid from cell membrane phospholipids.  
LPS – LPS binding proteins complex binds to CD14 antigen on 
surface of macrophages and results in release of various inflammatory 
mediators particularly tumour necrosis factor and interleukin-1.  TNF is one 
of the central mediators in pathogenesis of septic shock because it is   
responsible for various biological effects like fever, shock, myocardial 
depression, coagulation abnormalities, capillary leak and metabolic 
changes
7,8,9,10
. Interleukin – 1 causes fever by increasing prostaglandin E2 
 release in anterior hypothalamus. Platelet activating factor, another 
inflammatory mediator is released from activated macrophages. This factor 
is also produced by platelets and neutrophils. It stimulates cell adhesion and 
amplifies the action of cytokines.  
The factors which determine progression of sepsis to frank septic 
shock is not well understood. Two key factors are change in intravascular 
volume and myocardial dysfunction. Most of the inflammatory mediators 
like arachidonic acid metabolites, cytokines alter the capillary permeability 
leading to decrease in effective circulating volume. Depression of 
myocardial function is seen in children with septic shock. These patients 
have reduced ejection fraction, left ventricular dilatation and altered 
ventricular performance
11
. TNF and IL-1β are possibly the factors involved 
in myocardial depression. The inflammatory mediators alter perfusion in 
microcirculation causing increase in interstitial fluid. This affects the cellular 
oxygenation and metabolism causing tissue hypoxia. As the tissue hypoxia 
progresses, anaerobic glycolysis, metabolic acidosis and cell injury ensues 
leading to cell death and organ failure. 
CLINICAL FEATURES 
Full blown picture of septic shock is easily identified but early 
diagnosis is really challenging. It requires high index of suspicion and 
 knowledge about the disease. Early signs of septic shock are subtle and 
easily missed. Examination will reveal  
1. Mental Status 
 Altered mental status is one of the most important signs of shock.  
Restlessness, inconsolability, anxiousness, agitation, increased 
drowsiness must be noted. 
2. Skin  
  We should look for signs of poor peripheral perfusion like cold 
extremities, mottling, cyanosis. Temperature abnormalities such as 
hyper or hypothermia must be noted; any evidence of coagulopathy 
should be noted.  
3. Cardiovascular system 
 Due to stress various autonomic disturbances occur, of which 
tachycardia occurs early. Cardiac output is a product of stroke volume 
and heart rate. In children, cardiac output is mainly increased by 
increase in heart rate rather than stroke volume. Fall in blood pressure 
occurs late leading to decompensated state. In warm phase of septic 
shock, due to vasodilatation, there will be wide pulse pressure, 
bounding peripheral pulses, flash capillary refill. In cold phase, there 
will be tachycardia, cold extremities, weak peripheral pulses and 
 prolonged capillary refill time (>3 seconds). Warm shock if not 
recognized early or if untreated will eventually result in cold shock. 
4. Respiratory  system  
  Respiratory rate is increased as a result of compensation to 
metabolic acidosis. Uncorrected shock can lead to development of 
acute respiratory distress syndrome characterized  by the progressive 
worsening  of respiratory distress which manifests as tachypnoea, 
nasal flaring, intercostal, supra sternal and subcostal retractions with 
bilateral rales on auscultation. 
5. Urine  output  
  Decreased urine output occurs. In later stage it can lead to renal 
failure. 
INVESTIGATIONS 
                Complete blood count – will reveal anemia, leucocytosis, and 
thrombocytopenia.  Peripheral smear will show neutrophilic leucocytosis 
with shift to left, toxic granules, Dohle bodies. Leucopenia and neutropenia 
are observed in case of overwhelming sepsis. Other hematologic 
abnormalities are prolonged prothrombin and partial thromboplastin times, 
decreased serum fibrinogen, elevation of fibrin split products in case of 
disseminated intravascular coagulation. Other abnormalities which can occur 
 are hyperglycemia or hypoglycemia, hypocalcemia, hypoalbuminemia. 
Blood gas analysis reveals high anion gap with metabolic acidosis. Acute 
phase reactants like C - reactive protein, erythrocyte sedimentation rate will 
be elevated. Blood culture and other appropriate cultures are necessary to 
identify the organism. 
MANAGEMENT 
  
 Management of septic shock is complex   
 
It involves  
1. Emergency Resuscitation 
2. Timely  initiation of antimicrobial therapy 
3. Source Control  
4. Goal directed therapy for organ dysfunction 
1. Emergency Resuscitation
12 
 Emergency management include rapid cardiopulmonary 
assessment, careful and repeated physical examination. 
Golden hour of management  
0-5 min:  
1. By rapid cardiopulmonary assessment, recognize altered mental 
status and altered perfusion.  
 2. Administration of 100 % high flow oxygen is crucial. Venturi 
mask or non-rebreathing mask can be used for administering high 
flow oxygen. 
3. Establishment of intravenous access. If emergency intravenous 
access cannot be obtained, intraosseous access should be obtained.  
If airway is unstable or the patient is drowsy and unresponsive, 
Bag and Mask ventilation with 100 % oxygen should be started 
with plan for intubation and mechanical ventilation should be 
done. Other indications for intubation are   
 a) Hypotension on arrival or during treatment 
        b) Persistently low Glasgow coma scale score of less than 
eight   
         c) Convulsions not controlled even with two doses of 
benzodiazepines and with signs of raised intracranial tension. 
5-40 min: 
        Fluid boluses with isotonic crystalloid of 20 ml/kg should be given over 
20 minutes if blood pressure is normal; if there is hypotension, boluses 
should be given as rapidly as possible and up to 60 ml/ kg should be 
administered to achieve therapeutic end goal. During and after each bolus, 
assess for signs of fluid overload in the form of frothy secretions, rales, new 
 onset of signs of respiratory distress, hepatomegaly. In case of warm septic 
shock, shock due to gastrointestinal sepsis, fluid as much as 200 ml/kg may 
be required in the initial few hours. In malnourished children, administering 
rapid fluid bolus can cause fluid overload, so rate and volume of fluid should 
be slow and carefully titrated. 
40 – 60 min: 
 Shock not responding even after adequate intravascular volume 
repletion requires vaso active drugs. In children with fluid refractory 
hypotensive shock with low systemic vascular resistance, dopamine is the 1
st
 
line drug. Children with septic shock often have low cardiac output and 
myocardial dysfunction. So dopamine with or without dobutamine should be 
used. 
Dopamine: 
          It is a natural precursor of epinephrine and non-epinephrine. It is 
usually the inotrope of choice in septic shock. It possesses dose dependent 
effects. At low doses (1 - 5 µg/kg/min), its action is predominant on 
dopamine receptors resulting in selective vasodilatation in splanchnic, renal 
and coronary vessels. At moderate doses (5 – 15 µg/kg/min) it acts on β1–
adrenergic receptors causing increase in heart rate and myocardial 
 contractility. At doses (15 – 25 µ/kg /min) it causes arterial vasoconstriction 
by acting on α1 receptors.  
Dobutamine:  
 It is a β1 and β2 adrenergic agonist. It increases cardiac contractility (1 
- 20 µg/kg/min) with little effect on heart rate. Dobutamine causes after load 
reduction and is useful in cardiogenic shock. In septic shock, it should be 
used in combination with other vasopressors, because dobutamine can cause 
peripheral vasodilatation leading to hypotension. 
Adrenaline: 
 It is a potent β1 adrenergic agonist. Also has α1 and β2 adrenergic 
effect. Causes increase in heart rate, contractility. Used in doses of 0.1 – 1 
µg/kg/min adrenaline is a potent vasoconstrictor. Nor adrenaline increases 
blood pressure by increasing systemic vascular resistance. 
Vasopressin: 
 It is a natural hormone which causes vasoconstriction by acting on V1 
receptors. In sepsis Vasopressin stores are depleted and there is also down 
regulation of Vasopressin receptors. Infusion of low doses of Vasopressin 
helps in improving blood pressure
13
. Side effects include skin necrosis, 
intestinal ischemia and decreased cardiac output as a result of increased after 
 load. So Vasopressin is reserved for patients with significant vasodilatory 
shock.  
Milrinone: 
 It is a phosphodiesterase type 3 inhibitor. This enzyme causes 
degradation of intra cellular cyclic AMP. Blockade of this enzyme cause 
elevated levels of cyclic AMP which leads to improved contractility of heart 
and relaxation. In peripheral vessels it causes vaso dilatation. Useful in 
children with normotensive, catecholamine resistant shock with low pulse 
pressure and increased systemic vascular resistance. Milrinone has longer 
elimination half-life and cause hypotension. So careful monitoring of blood 
pressure is important. 
 
 
 
 
 
 
 
 
 
 FIGURE 3: 
Goal – Directed Step wise Management
14
. 
 
 Beyond one hour: 
Fluid refractory, dopamine, dobutamine resistant shock – shock not 
corrected even dopamine and or dobutamine infusion. These children require 
close monitoring in intensive care unit with Central venous pressure, mean 
arterial pressure, echocardiography. Further treatment should be based on 
CVP, echocardiography for titrating fluids and inotropes.  
Blood and component therapy 
The appropriate haemoglobin (Hb) in children with severe sepsis is 
debatable. Studies in children with septic shock are limited. Based on adult 
studies Hb level of 10g/dl during resuscitation is recommended.  
Fresh Frozen plasma  
Unnecessary use of Fresh frozen plasma exposes children to hazards of 
transfusions. It is indicated only in patients with coagulation abnormality 
and is bleeding actively. Also just before surgery or invasive procedures. 
Acid base and electrolyte abnormalities 
In sepsis, there is increased catabolism and increased requirement of 
glucose. So children are prone for hypoglycemia. Blood sugar should be 
monitored and hypoglycemia must be treated. Ionised calcium levels are 
commonly low in children with septic shock (< 4.5 mq/l). This leads to 
myocardial dysfunction should be corrected by i.v. Calcium. 
 2. Timely initiation of antimicrobial therapy 
Antibiotics should be administered within the 1
st
 hour preferably after 
obtaining appropriate culture. Early and appropriate antimicrobial therapy is 
one of the corner stone’s in treatment. Timely antimicrobial therapy 
determines outcome. Empirical antibiotics administered should be broad 
spectrum covering common offenders in the particular age group. In 
neonates, most common pathogens are group B streptococci, gram negative 
enteric bacteria and Listeria monocytogenes. In infants and children beyond 
neonatal period Streptococcus pneumoniae, Hemophilus influenza is a 
common organism. 
Empirical therapy for neonates is a combination of third generation, 
cephalosporin and aminoglycoside. For Infant and children, third generation, 
cephalosporin is the initial choice
1
. 
Penicillin resistant pneumococci, community or hospital acquired MRSA - 
vancomycin should be added to empiric therapy. 
Intra- abdominal condition - antibiotic covering anaerobes like 
metronidazole, clindamycin or piperacillin – tazobactum must be added 
Clinical suspicion of herpes simplex infection - acyclovir 
 Hospital acquired sepsis - 3
rd
 or 4
th
 generation Cephalosporin or Piperacillin 
– tazobactum with an aminoglycoside.  Empiric antifungal therapy should be 
considered in patients with immunosuppression. 
The recommendations for antimicrobial therapy are broad, generalised. 
Therapy must be modified according to clinical situation and local resistance 
pattern. Further treatment should be guided based on culture and sensitivity 
results. 
3. Source control  
Source of sepsis should be sought. This should go hand in hand with 
resuscitation. Example incision and draining of abscess, debridement of 
necrotic tissue, removal of infected device.  
4. Goal directed therapy for organ dysfunction 
Cardiovascular system dysfunction 
 Children with septic shock and myocardial dysfunction are difficult to 
manage. These children should be treated cautiously with small volume 
usually 5 ml/kg fluid boluses and early inotropes. Beyond the 1
st
 hour, 
stabilization of cardiovascular system should be directed to achieving 
normal mixed venous oxygen saturation. Normally oxygen delivery exceeds 
oxygen consumption by threefold. The oxygen extraction ratio is about 25%. 
Normal SVO2 (Mixed Venous Oxygen Saturation) is 75 to 80%. A 
 decreasing SVO2 implies increasing oxygen extraction ratio and decrease in 
oxygen delivery to tissues. A normal SVO2 indicates adequate oxygen 
delivery at cellular level
1
. 
Nor adrenaline and more fluids are useful in children with persistent 
warm shock. In children with Nor-adrenaline resistant shock, Vasopressin is 
found to be useful. Vasopressin can overcome alpha receptor desensitization 
and improve vascular tone. Children with cold shock and normal blood 
pressure improve with fluid and decreasing after load. The 
phosphodiesterase type III inhibitors like milrinone can overcome β – 
adrenergic desensitization. In those children with cold shock and 
hypotension, treatment is difficult. They can be treated with more fluids and 
adrenaline.  
Respiratory system dysfunction  
In children with acute respiratory distress syndrome, goal is to treat 
hypoxia and respiratory acidosis. These children have respiratory muscle 
fatigue. So early endotracheal intubation and ventilation should be 
performed. During mechanical ventilation, lung – protection strategies 
should be adopted to reduce ventilator induced lung injury. This is because 
volutrauma and barotraumas can lead to disruption of alveolar and capillary 
endothelial tight junctions. This causes exudation of fluid and protein in 
 alveoli which in turn attract inflammatory cells. The cytokines and 
inflammatory mediators exacerbate the injury decrease surfactant production 
further impairing gas exchange. Avoidance of tidal volume ≥ 10 ml/kg and 
plateau pressure ≥ 30cm H2O decrease alveolar damage
1
. Provision of 
adequate positive end expiratory pressure is another strategy. Inappropriate 
PEEP can lead to atelectrauma. Also maintaining an adequate PEEP, helps 
in decreasing inspired oxygen concentration which in turn limits occurrence 
of oxytrauma. Ventilator associated pneumonia can be prevented by 
elevation of head of the bed to 30 degrees and effective oral, endotracheal 
suctioning. 
Gastrointestinal dysfunction  
In shock, there is reduced blood flow to gastrointestinal system. 
Decreased splanchnic perfusion causes mucosal barrier dysfunction and can 
lead to translocation of bacteria and endotoxin into blood stream. Children 
with sepsis are at increased risk of malnutrition  
This is because  
1. Protein energy malnutrition is commonly found in children with 
sepsis. This is a main problem particularly  in countries like  India  
2. Child with illness often has reduced appetite. 
 3. In sepsis metabolic demand is increased due to fever, tissue  
catabolism 
Provision of adequate nutrition support is very important. Whenever 
possible, enteral feeding is better than total parenteral nutrition. Improved 
survival and decreased hospital stay has been observed in critical ill patients 
with use of early enteral feeds 
Endocrine Dysfunction:  
1. Disturbance in glucose metabolism occurs more often in children 
with sepsis. Both hypo and hyperglycemia can occur. Hypoglycemia 
occurs more commonly in neonates and its consequence can be 
devastating. Similarly hyperglycemia is also harmful. There is 
increased risk of infection and delayed wound healing due to 
impaired neutrophil function, can occur. Insulin can be used to 
control hyperglycemia but may lead to hypoglycemia. 
2. Adrenal insufficiency can occur in children with sepsis. The role of 
corticosteroid therapy in children with septic shock has been 
extensively investigated. Stress doses of hydrocortisone 50 mg /m
2 
/ 
dose should be used in children with fluid refractory, catecholamine 
resistant shock. 
 
 Renal dysfunction: 
 Acute renal failure is a common complication in patients with sepsis. 
These patients pose additional problems because of difficulty in fluid 
management and dysfunction in clearance of toxins. Administration of 
continuous renal replacement therapy is useful in sepsis. The advantages are 
1. Removal of toxins and harmful mediators 
2. Adequate calories can be provided without exacerbating fluid 
overload. 
Pneumonia:  
Pneumonia is an important cause of mortality in children under 5 years 
in developing countries. Causative organisms vary according to age, host 
and environmental factors.  
Causes: 
1. Bacterial    
  In New-borns 
  Group –B Streptococci 
  E.Coli 
  Klebsiella 
  Listeria monoytogenes 
  Staphylococcus aureus  
 In Older children  
  Streptococcus pneumoniae  
  H.Influenzae 
  Staphylococcus aureus 
2. Non-bacterial  
                   Rickettsia 
                   Pneumocystis jiroveci  
        Viruses    
Respiratory synctial virus, Cytomegalovirus, Herpes 
simplex virus, Epstein – Barr virus, Human 
metapneumovirus, adenovirus, rhinovirus, enterovirus.  
Important factors in development of bacterial pneumonia are 
virulence of the pathogen, absence of specific humoral immunity and 
presence of viral upper respiratory tract infection. Most pneumonia is the 
result of colonization of nasopharynx followed by aspiration or inhalation. 
Viral infection causes destruction of respiratory epithelium or up regulation 
of bacterial adhesion molecules. 
Clinical features: 
In young infants, fever, chills, rigors, restlessness, poor feeding, 
gastrointestinal complaints, difficulty in breathing occurs. In new-born 
 episodes of apnoea, cyanosis, bradycardia can occur. On examination, signs 
include tachypnoea, dyspnoea, grunting, added sounds. Abdomen distension 
may result from paralytic ileus or swallowed air. 
Acute non-bacterial pneumonia are characterised by coryza, low grade 
fever, decreased appetite. Dehydration can occur because of fever, 
hyperventilation and decreased intake. On auscultation fine crackles may be 
present. Wheezing may occur when there is associated bronchospasm. 
Cyanosis in older children is an ominous sign. 
 Diagnosis: 
WBC count is increased. Counts >15,000 /cu.mm is commonly seen 
in bacterial pneumonia. Leucocytosis is also seen in influenza and Para 
influenza infection. Counts < 5000 /cu.mm are associated with severe 
overwhelming infection. Elevated acute phase reactants are seen. Chest x-
ray findings in bacterial pneumonia are lobar consolidation, pleural effusion, 
and pneumatoceles. In non-bacterial pneumonias, usually air trapping, 
perihilar infiltrates occur. Patchy areas of consolidation indicate lobular 
atelectasis. X –ray findings do not correlate with clinical findings in most 
situations.  
Gram stain, culture of sputum helps in identifying causative organism. 
Other specimens include nasopharyngeal secretions, tracheal aspirations, and 
 bronchoalveolar lavages. Polymerase chain reaction for pneumococcus. 
Polysaccharide antigen in urine for pneumococci, H.Influenzae  
Treatment:  
Treatment of pneumonia involves specific therapy and supportive 
measures. In case of non – bacterial pneumonia therapy is primarily 
expectant and supportive. Administration of warm, humidified oxygen 
correction of dehydration and monitoring is necessary. 
In case of fulminant varicella zoster pneumonia, therapy with 
acyclovir is indicated. Progressive Cytomegalovirus interstitial pneumonia is 
treated with ganciclovir and immunoglobulin. Epidemics of influenza are 
treated with oseltamivir. Pneumocystis jiroveci pneumonia is treated with 
Cotrimoxazole or Pentamidine. Inhaled Ribavirin is useful in treating 
Respiratory syncitial virus pneumonia.  
Meningitis:  
 Meningitis is inflammation of meninges. Even though antibiotic 
therapy has improved prognosis in meningitis; it still continues to be an 
important cause for morbidity and mortality.  
Causes: 
In New born 
              Gram negative enteric organisms are most common. 
 In infants and children 
                H.Influenzae, Streptococcus pneumoniae and Staphylococcus 
aureus. 
Pathogenesis: 
Most cases of bacterial meningitis infect the meninges by following 
steps  
i. Colonization of upper respiratory tract  
ii. Invasion of blood from respiratory focus 
iii. Seeding of meninges and then inflammations 
Less commonly, lepto meningeal inflammation can result from contiguous 
spread or hematogenous dissemination from a remote site.  
Once in the blood stream, the common pathogens are capable of 
evading host immune responses the capsular polysaccharides inhibit 
neutrophil phagocytosis and complement system. The specific 
pathophysiological changes are due to bacterial products and the 
inflammatory response of the host to those products. TNF – α and IL -1 
Once in the blood stream, the common pathogens are capable of evading 
host immune responses the capsular polysaccharides inhibit neutrophil 
phagocytosis and complement system. The specific pathophysiological 
changes are due to bacterial products and the inflammatory response of the 
 host to those products.TNF – α and IL -1 are key mediators in initiation of 
meningeal inflammation. These cytokines activate adhesion molecules 
attract neutrophils, activate complement system. 
Clinical features: 
Children usually present with nausea, vomiting, lethargy or 
irritability, headache, bulging fontanels. Neck rigidity, photopobia, seizures, 
hemiparesis, transient or permanent cranial nerve palsies may be presenting 
feature. Kernigs and Brudzinski signs are result of irritation of inflammed 
sensory nerves. These signs are minimal in infancy  
Diagnosis: 
Lumbar puncture and CSF analysis must be done as early as possible 
unless specific contraindications are present. Gross examination of CSF, 
pressure, microscopic examination for cells, gram stain, biochemical 
analysis, culture and sensitivity should be done. In children older than 3 
months, presence of polymorpho nuclear leucocyte is abnormal. Proteins 
will be elevated (100 – 500 mg/dl) and sugar will be decreased (< 40 mg/dl). 
Latex particle agglutination for polysaccharide antigens can be done. 
Polymerase chain reaction analysis of CSF can be used to detect microbial 
DNA. CSF –lactate and lactate dehydrogenase will be increased. pH will be 
decreased. CT and MRI brain are helpful in detection of ventricular 
 dilatation, presence of infarcts, subdural effusion, and meningeal 
inflammation. 
Treatment: 
Third generation cephalosporins – Cefotaxime in the dose of 225 to 
300 mg/kg/day or Ceftriaxone 100 mg/kg/day along with Vancomycin 60 
mg/kg/day is an appropriate empirical therapy. Vancomycin is 
recommended in addition because of the increased frequency of Penicillin 
and Cephalosporin resistant pneumococci. Ceftazidime is efficacious in the 
treatment of meningitis due to Pseudomonas. 
Corticosteroids - dexamethasone 0.15 mg/kg/dose 6th hourly for 2 days is 
recommended as an adjunct therapy in bacterial meningitis because  
1. They  decrease  intracranial pressure 
2. Reduce meningeal inflammation by acting on cytokines  
3. Decrease the incidence of sensorineural hearing  loss15,16 
Other supportive therapies include agents to reduce intracranial pressure, 
fluid restriction in case of SIADH (Syndrome of Inappropriate Anti Diuretic 
Hormone secretion), control of seizures, management of nutrition electrolyte 
imbalances. 
 
 
 Urosepsis: 
Urinary tract infections are an important cause of fever without focus 
in young children. Acute pyelonephritis can present as septicemia 
Causative organisms: 
Escherichia coli – the most common 
Klebsiella  
Proteus  
Enterobacter 
Serratia 
Pseudomonas  
Rare causes include Staphylococcus aureus, Hemophilus influenzae 
and Streptococcus pneumoniae. 
Clinical features: 
In neonates, UTIs present as late onset sepsis. In infants and young 
children they may present as fever with chills and rigor, irritability, poor 
feeding, back pain, vomiting, loose stools, and oliguria.  Lower urinary tract 
symptoms may or may not be present. On examination dehydration, renal 
angle tenderness may be present. 
 
 
 Diagnosis: 
Examination of urine reveals pyuria. Microscopic hematuria, 
proteinuria can be present in some cases. Urine dipstick can be positive for 
leucocyte estrase, nitrite. Significant bacteriuria is defined as  > 10
5   
CFU / 
ml in clean catched  mid – stream urine sample ;  In catheter specimens       
>  5  X 10
4 
 CFU / ml is significant and any colony count in urine obtained 
by supra pubic aspiration is significant. 
1) The growth of organism in urine culture is necessary for 
diagnosis  
2) Renal scintigraphy with Tc 99m DMSA is the most reliable 
method for detecting acute pyelonephritis which will reveal 
decreased uptake in affected areas  
3) An USG abdomen examination is useful to detect associated 
anomalies. 
Treatment:  
Second or third generation cephalosporin for 7 - 10 days is effective in 
most of the cases. 
Gastro intestinal infections: 
Gastrointestinal infections causing septicemia usually result from 
gastro enteritis and intra abdominal abscesses. 
 Etiology of gastroenteritis: 
The common bacteria causing gastroenteritis are Escherichia coli, 
Shigella, Salmonella, Vibrio cholera, Clostridium, Campylobacter, Yersinia 
enterocolitica and Aeromonas hydrophila.  
The common bacteria causing intra abdominal abscesses are 
Enterobacteriaceae, Bacteroides and Peptostreptococcus. Intra-abdominal 
abscesses are classified as intraperitoneal, visceral and retro peritoneal. Most 
common are intraperitoneal abscesses associated with appendicitis and 
trauma. Visceral abscesses occur commonly in liver, pancreas and spleen. 
Clinical features: 
Fever, malaise, vomiting, loose stools – watery or mixed with blood 
and mucus, abdominal pain. Dehydration can occur as a result of excessive 
fluid loss. 
Diagnosis: 
History, stool examination – microscopy for faecal leucocytes, RBCS. 
Presence of faecal leucocytes indicates that a patient has colitis. Stool 
culture for gram negative enterobacteriaceae should be done. In case where 
Vibrio cholera, Yersinia, Clostridium and Listeria are suspected, special 
media are needed. 
 
 Treatment: 
 Fluid, electrolyte and nutritional support are very essential. Most 
infections are self-limited. Third generation Cephalosporins or Co-
trimoxazole or Fluoro quinolones are effective in most cases. In cases of 
sepsis associated with Campylobacteria or Yersinia aminoglycosides are 
alternatives. 
INTRA ABDOMINAL ABSCESS 
Clinical features:  
Fever, abdominal pain and tenderness over affected area are 
presenting feature in case of abscess. The symptoms are non-specific like 
fever, nausea, anorexia, vomiting. Other less common manifestations are 
hepatomegaly, jaundice, abdominal pain, and abdominal distension. 
Subphrenic abscesses present with respiratory symptoms and referred pain. 
Splenic abscess present with tender splenomegaly. Retroperitoneal 
infections present with fever, pain in hip and back, limping in case of 
ileopsoas abscess. 
Diagnosis: 
Plain X-rays show extra intestinal air fluid level, localized ileus in 
case of pelvic abscess and elevated diaphragm, right pleural effusion in case 
of liver abscess. 
 USG abdomen can detect abscess. CT with contrast enhancement is 
the most sensitive tool for detecting intra-abdominal abscesses. Extent of 
involvement and good anatomic resolution is possible. Abscess fluid is seen 
as areas of low attenuation with enhancing rim. Leucocytosis, elevated acute 
phase reactants, blood cultures may be helpful.  
Treatment: 
Surgical drainage either open or percutaneous under CT or USG 
guidance is often required. Empirical therapy with antibiotics covering 
Enterobactericeae, anaerobes should be administered. In case of liver 
abscess, anti-Staphylococcal agents should be added. Previously Ampicillin 
+ Metronidazole + 3
rd
generation Cephalosporin was used. β – lactamase 
inhibitors combinations such as Piperacillin - tazobactum with an 
aminoglycoside are also effective. Monotherapy with carbapenams are cost 
effective alternative. Duration of therapy should be minimum 4 weeks. 
 
 
 
 
 
 
 Musculo skeletal infections: 
This includes osteomyelitis, septic arthritis, and myositis. 
Osteomyelitis occurs more common in 1
st
 two decades of life. The micro-
organism reaches bone in three ways. 
1. Direct inoculation usually traumatic  
2. Local invasion from nearby focus 
3. Hematogenous  
Etiology: 
Bacterial infections are most common 
Staphylococcus aureus    
Group A streptococcus  
H.Influenzae  
Kingella kingae 
Streptococcus pneumoniae 
In neonates,  
Gram negative organism 
Group – B streptococcus 
Puncture wound osteomyelitis - Pseudomonas 
 
 
 Clinical features: 
Newborn - irritability, pseudoparalysis, fever, refusal of feeds and 
others features of septicemia. Infants and young children – limp, refusal to 
move affected extremities, constitutional symptoms. Older children - limp, 
fever, point tenderness. On examination, swelling of affected extremity, 
tenderness, restriction of movements will be present. 
Diagnosis: 
Suspected based on clinical findings. 
 Aspirate of affected bone, joint fluid reveal microorganisms. 
Histopathology of surgical specimens can also be helpful. 
Leucocytosis elevated CRP, ESR, blood cultures. 
Plain X-ray 
 In osteomyelitis -occur in 3 stages 
Stage 1: Within 3 days of onset of symptoms -localized, deep soft 
tissue swelling. 
Stage 2: 3-7 days after onset of symptoms. Swelling of muscles with 
obliteration of interposed translucent fat planes. 
Stage 3 :(10 to 21 days) subperiosteal bone resorption, area of bone 
destruction and periosteal new bone formation. 
In septic arthritis - capsular swelling 
 In myositis - soft tissue swelling, widened fascial plane  
MRI: 
Imaging modality of choice in osteomyelitis. Accurately delineates 
the pus collection, extent of involvement. T1 weighted images show 
decreased signal due to marrow edema and T2 weighted images show 
increased signal intensities. 
USG: 
It helps in identifying fluid collection in joint, muscle abscess. 
Technetium (Tc 99 m) bone scan - reveals increased up take in affected area. 
Treatment: 
In case of muscle abscess - surgical drainage is necessary. Septic   
arthritis - arthrotomy, drainage. Osteomyelitis – Surgical exploration, if 
medical treatment fails. Depending on etiology parenteral antibiotics is 
chosen. Since Staphylococcus aureus is the commonest organism 
intravenous Naficillin or Oxacillin (200 mg/kg/day) is the initial choice. 
When MRSA is suspected – i.v. Clindamycin (40 mg/kg/day) or 
Vancomycin (60 mg/kg/day) is used. For H.influenzae – i.v. 3rd generation 
cephalosporin is the initial choice. In case of Pseudomonas or gram negative 
 enteric organism – ceftazidime and aminoglycoside combination should be 
used. In case of anaerobic infection clindamycin should be added. 
LACTATE  
HISTORY 
Karl Wilhelm Scheele, a Swedish chemist first described lactate in 
1780
17
. He discovered lactate in sour milk. Jon Jacob Benzalieus described 
the same in the year 1807 in muscle tissue of hunted stage
17
. Trasaburo 
Araki and Herman Zillessen demonstrated the relationship between tissue 
hypoxia and lactate production
18
. In humans lactate in blood was first 
demonstrated in women who died of pueperal fever in 1843 by German 
physician and chemist, Joseph Schere
19
. In living patients, it was 
demonstrated by Carl Folworezing in 1858
17
. 
Initially, hyperlactatemia was considered primarily as a result of 
anaerobic metabolism due to inadequate tissue oxygen delivery. Only in 
later half of 20
th
 century, understanding of elevated serum lactate has 
changed. Importance of hyperlactatemia included disease states other than 
tissue hypoxia. 
 
 
 
  FIG 4: LACTATE METABOLISM 
 
   
 LACTATE – METABOLISM  
Glucose is metabolised via glycolytic pathway in the body to pyruvate. 
Pyruvate once generated can enter into any one of the following pathways  
(i) Tricarboxylic acid pathway or citric acid cycle in the mitochondria 
to produce energy in the form of ATP. Under aerobic condition 
through oxidation 38 molecules of ATP can be produced. 
(ii) Can be converted to lactate by enzyme lactate dehydrogenase. 
(iii) Can be directed to gluconeogenesis for glucose production. 
(iv) Production of alanine by transamination. 
Normal lactate production is about 0.8 mmol/kg/hr.  All tissue can produce 
lactate. Under physiologic conditions, source of lactate production include 
skin (25%), skeletal muscle (25%), brain (20%), erythrocytes (20%) and 
intestine (10%). Metabolism of lactate occurs mainly in liver. About 60% of 
lactate produced, enter periportal hepatocytes and get converted to glucose 
and glycogen via the Cori cycle. 
Conversion of pyruvate to lactate occurs under certain circumstances
20
  
1. Glycolysis requires NAD+ which is produced to some extent by 
pyruvate to lactate conversion. Presence of NADH controls the above 
rate of conversion. Mainly Malate aspartate shuttle and to certain 
extent glycerol phosphate shuttle pathway help to keep NADH levels 
 low. If the rate of glycolysis surpass the ox-phosphate shuttle systems, 
concentration of NADH rises and thereby lactate production also 
increase. 
2. Increased aerobic glycolysis  
(i) Seen  in response to cytokine release, at site of  infection, 
inflammation 
(ii) Systemic hypoperfusion as in shock. 
(iii) Hypoxemia. 
(iv) Increased catecholamines  as in Pheochromocytoma 
3. Decreased activity of pyruvate dehydrogenase  
(i) Congenital abnormalities of  pyruvate dehydrogenase 
enzymes 
(ii) Deficiency of co-factor – thiamine  
4. Decreased clearance  
(i) Impaired liver  function 
(ii) Mitochondrial dysfunction 
(iii) Drug like metformin inhibit gluconeogenesis  
(iv) Alcohol intoxication causing impaired gluconeogenesis 
and also impaired  pyruvate dehydrogenase activity  
 In physiological conditions lactate is not normally excreted by kidneys, 
because the renal threshold is approximately 5 to 6 mmol/l
20
. Renal cortex 
produce glucose from lactate by gluconeogenesis. When renal blood flow is 
compromised as in septic shock, clearance of lactate can be impaired 
causing elevated lactate levels. 
LACTATE AND SEPTIC SHOCK: 
Many pathological conditions cause elevation of lactate level by 
increased production or impaired clearance. In septic shock, increase in 
lactate occurs due to tissue hypoxemia, hypermetabolism and impaired 
clearance
21
. These findings make serum lactate - a potential biomarker in 
children with septic shock. 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
Koliski et al conducted a prospective observational study in 75 
children admitted in intensive care unit for various illnesses. Patients were 
divided into two group based on lactate level. Mortality was higher in 
patients with lactate ≥ 18 mg/dl (30% versus 12%). Lactate level at 24 hours 
had best sensitivity 55.6 % and specificity 97.2%. They reported that chance 
of survival was high if lactate level was reduced within 24hours of 
admission
22
. 
Kana ram Jat et al conducted a prospective observational study in 30 
children admitted to PICU with septic shock. Their aim was to correlate 
serum lactate level in children with septic shock with survival. Serum lactate 
level was measured in arterial blood 0 - 3, 12 and at 24 hours after 
admission. PRISM –III score and demographic characteristic of all children 
were recorded. Primary outcome measured was survival or death. Analysis 
revealed higher lactate levels among non-survivors compared to survivors. 
Lactate value of more than 45 mg/dl (5 mmol/l) was significantly associated 
with poor outcome. Lactate levels also correlated with PRISM III score
23
. 
A prospective cohort study was conducted by Scott et al in children 
younger than 19 years. Their objective was to test the utility of serum lactate 
testing in pediatric emergency department patients with system 
 inflammatory response syndrome. Outcome measured was organ 
dysfunction within 24 hours of triage. Secondary outcomes measured were 
disposition, serious bacterial infection, treatment and mortality. 239 children 
were subjects. The hyperlactatemia group (lactate > 4 mmol/l) had a relative 
risk of 5.5 of developing organ dysfunction at 24 hours. In hyperlactatemia 
group, the sensitivity was 31% and specificity was 94% for predicting organ 
dysfunction. They concluded that early hyperlactatemia is significantly 
associated with increased risk of organ dysfunction, resuscitative therapies, 
admission to intensive care unit and bacterial infection
24
. 
Zhoux et al retrospectively studied the relationship between blood 
lactate level and disease severity in 232 critically ill children. According to 
blood lactate level within 24 hours of admission, patients were classified 
into three groups: Normal, high lacticemia and lactic acidosis groups. 
Pediatric critical illness score and prognosis were compared among the three 
groups. Prognosis in lactic acidosis group was significantly lower and 
mortality (28.6%) was significantly higher than in normal group
25
. 
Duke et al conducted a prospective study among 31 children admitted 
with sepsis. Their objective was to assess the markers of perfusion which 
best discriminate survivors from non-survivors. Arterial lactate was 
measured at admission, 12, 24 and 48 hours. The positive predictive value 
 for death was 56% for blood lactate level greater than 3 mmol/L measured at 
12 hours. The positive predictive value for death was 71% for blood lactate 
level greater than 3 mmol/l measured at 24 hours. Blood lactate was the 
earliest predictor of outcome of 56% in children with sepsis
26
. 
Garcia Sanz et al performed a prospective study in 500 consecutive 
children admitted to PICU. Their objective was to analyse and compare the 
prognostic value of blood lactate and pediatric index of mortality (PIM) 
score on admission to PICU. Predictive ability of PIM score and lactate 
relating to mortality and duration of stay in the hospital were analysed. Mean 
probability of death according to PIM score was significantly higher in non-
survivors. Lactate concentration in non-survivors was 3.5 mmol/l which was 
statistically significant when compared to survivors, 1.5 mmol/l (P < 
0.001).The area under ROC curve was 0.76 [95% CI 0.67 to 0.85] which 
was also significant  p< 0.04
27
. 
Hatherill et al conducted a prospective study to examine relationship 
between early hyperlactatemia, acidosis and mortality in children admitted 
to intensive care. 755 critically ill children were screened. 50 children with 
hyperlactatemia were studied. PRISM score, length of stay in PICU and 
outcome were analysed.  Mortality in study group was 64 %. In non-
survivors, median  peak lactate level was  6.8 mmol/l, which was 
 significantly higher compared to survivors  5 mmol/l. Average lactate level 
was  2.4 mmol /L in survivors, compared to 4.5 mmol/l in non survivors ( P 
= 0.0003). They concluded that persistent hyperlactatemia even after 24 
hours of admission is associated with higher mortality in critically ill 
children
28
. 
Prospective study was conducted by Barat Ramakrishna et al to 
determine whether blood lactate measured at time of presentation to hospital 
predicted outcome in children with pneumonia. The relative risk of death if 
lactate level above 2 mmol/l was 7.48, sensitivity was 92%, specificity was 
39%, Multivariate analysis showed that hypoxemia, hyperlactatemia, age ≤ 
12 months were independent risk factors for death from pneumonia
29
. 
          Mark E.Mikkelson et al performed a retrospective cohort study in 
adult patients presenting to the emergency department with severe sepsis. 
830 patients was included. Primary objective of the study was to find 
whether the association between initial serum lactate and mortality is 
significantly related to clinically apparent organ dysfunction and shock. The 
primary outcome measured was 28 day mortality. 60 days mortality was 
considered as secondary outcome. Initial venous lactate was categorised as 
low (< 2 mmol/l), intermediate (2 - 3.9 mmol/l) or high (≥ 4 mmol/l). They 
 reported that intermediate and high serum lactate levels are independently 
associated with mortality
30
. 
          In a study performed by Hussain et al, lactate level was measured at 
admission and at 24 hours. 137 surgical intensive care unit patients were 
studied. Initial and 24 hours lactate level was significantly elevated in non 
survivors versus survivors (p = 0.002). Mortality also increased with 
increasing time for normalization of lactate.  Mortality rate was 10% if 
lactate normalized within 24 hours, 24% for > 48 hours and 67% if lactate 
did not return to normal
31
. 
Marecaux et al conducted a prospective observation study on 38 
adult patients with septic shock. Serum levels of tumour necrosis factor – 
alpha, interleukin - 6 and blood lactate were measured serially at admission, 
24 and 48 hours. Admission blood lactate levels were higher in non 
survivors than survivors and decreased significantly in survivors than non-
survivors. They also reported that blood lactate was a better prognostic 
indicator than TNF - α and 
IL – 6
32
. 
Phua J et al compared the prognostic utility of lactate procalcitonin, 
amino terminal pro – B – type natriuretic peptide with each other and with 
cytokines like interleukin – 1 β, interleukin – 6 and TNF α levels and clinical 
 severity scores and their prognostic utility in septic shock. 72 adult patients 
with septic shock were studied. The biomarkers were measured on first 3 
days of stay in intensive care unit. Rising trend in lactate and procalcitonin 
level between day 2 and 3 were better prognostic indicators. They concluded 
that serial lactate level will be useful for prognostication in septic shock
33
. 
A Prospective cohort study in 32 adult patients with septic shock was 
studied by Bernardin G et al to identify early prognostic markers of septic 
shock. Mean arterial blood pressure and lactate were measured at admission 
and at 24 hours. Among 32 patients, 18 survived. After 24 hours, non – 
survivors had significantly lower mean arterial blood pressure and higher 
lactate level (p < 0.01) than survivor. 24 hours changes of lactate and blood 
pressure were also of prognostic value. Lactate level equal to or greater than 
3.5 mmol/ l was independently associated with poor survival
34
. 
Murat Basaran et al conducted a prospective observational study in 
60 infants operated for congenital heart diseases. Serum lactate was 
measured at 3 hours, 6 hours and 12 hours post operatively. Blood lactate 
level of 4.8 mmol/l was taken as threshold. Mortality was significantly 
higher in children with lactate > 4.8 mmol/l
35
. 
A prospective observation study comparing prognostic value of blood 
lactate, gastric intramucosl pH in patients with severe sepsis was conducted 
 by Friedman .G et al. 35 consecutive patients with severe sepsis were 
included in the study. There was no significant difference in blood lactate 
concentration between survivor and non-survivors [3.2 ± 1.5 Vs 2.8 ± 2.3 
meq/l]. But 4 hours and 24 hours lactate remained high in survivors and 
progressively decreased in survivors. Both lactate and intramucosal pH were 
reliable prognostic indicators in severe sepsis
36
. 
A prospective cohort study was carried out in emergency department 
by Hisamuddin et al. 51 adult patients with sepsis induced hypotension and 
septic shock was included. Outcome measured was 30 day mortality. 
Twenty two deaths occurred within 30 days follow up. Overall mean lactate 
was 3.52 mmol/l. Analysis revealed an increase in lactate level in emergency 
department was associated with an increased risk of death. For every 
increment of lactate value of 1 mmol/l hazards of dying are expected to 
increase by 1.5 times (p < 0.001)
37
. 
         Ole kruse et al performed a systematic analysis of about 66 articles 
using Pub med, Cochrane, Central Register of Controlled trial, Cochrane 
database of systemic review. Finally 33 articles were selected for analysis. 
Their aim was to examine whether blood lactate levels are predictive of 
hospital mortality in acute care settings which included, patients assessed 
pre-hospital, in trauma center and Intensive Care Unit. The review 
 concluded that blood lactate is useful for risk assessment in acutely ill 
patients. Serial lactate is useful in predicting in hospital mortality. Lactate 
level greater than 2.5 mmol/l should be closely monitored for signs of 
deterioration
38
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 JUSTIFICATION OF THE STUDY 
Sepsis and septic shock is one of the leading causes for admission in 
intensive care unit. Septic shock causes millions of children deaths every 
year. Mortality is high even with advanced intensive care. Studies have been 
conducted and new researches are ongoing to find biomarkers which will 
help in early identification, prognostication and treatment in critically ill 
children. This will help to reduce morbidity and mortality. Studies in adults 
have demonstrated that serum is a useful predictor of outcome in septic 
shock. Studies in children are limited. This study aimed to correlate serum 
levels of lactate with the poor outcome and its usefulness in predicting the 
mortality in children with septic shock. 
 
 
 
 
 
 
 
 
 
 OBJECTIVES OF THE STUDY 
1.  To determine the association between serum lactate level and 
mortality in pediatric septic shock. 
2.  To determine whether serial determination of serum lactate level is a 
predictor of outcome in pediatric septic shock. 
3.   To determine the association between organ dysfunction, presence of 
anemia, malnutrition, diagnosis and outcome in pediatric septic shock. 
 
 
 
 
 
 
 
 
 
 
 
 
 SUBJECTS AND METHODS 
STUDY DESIGN:  
Nested case control study 
STUDY PLACE:   
Pediatric Intensive Care Unit, Coimbatore Medical College and 
Hospital 
STUDY PERIOD:  
December 2011 – September 2012 
STUDY POPULATION: 
3 months – 12 years children admitted in PICU with septic shock 
INCLUSION CRITERIA 
All Children from age of 3 months to 12 years admitted with septic 
shock in PICU during the study period between 7am and 7 pm. 
EXCLUSION CRITERIA 
1. Children who received pre-hospital treatment in the form of fluid 
boluses. 
2. Inborn errors of metabolism. 
SAMPLE SIZE: 
     Sample size was estimated using the formula, Y= (µ1-µ2)/σ 
      Y-difference between two population means 
       σ -population standard deviation 
Based on Previous studies, 
µ1 = 5.49, µ2 = 5.21, SD or σ = 0.56 and Y=0.5 
Corresponding to power at 0.50, estimated sample size was 49. 
SAMPLING TECHNIQUE: 
Children admitted with septic shock on consecutive days between 7 
am and 7 pm during the study period. 
DEFINITIONS: 
SIRS (Systemic Inflammatory Response Syndrome)
39 
The presence of at least two of the following four criteria, one of which must 
be abnormal temperature or leukocyte count: 
1) Core temperature of > 38.5°C or < 36°C. 
2) Tachycardia, defined as a mean heart rate > 2 SD above normal for 
age in the absence of external stimulus, chronic drugs, or painful 
stimuli; or otherwise unexplained persistent elevation over a 0.5 to 
4 hr time period. 
Or 
For children < 1 year old: bradycardia, defined as a mean heart rate < 10th 
percentile for age in the absence of external vagal stimulus, beta-blocker 
 drugs, or congenital heart disease; or otherwise unexplained persistent 
depression over a 0.5 hr time period. 
3) Mean respiratory rate greater than two standard deviation above 
normal for age or need for mechanical ventilation. 
4) Increased or reduced white blood cell count for age (not secondary 
to chemotherapy-induced leukopenia) or > 10% immature 
neutrophils. 
Infection 
A suspected or proven (by positive culture, tissue stain, or polymerase 
chain reaction test) infection caused by any pathogen OR a clinical 
syndrome associated with a high probability of infection. Evidence of 
infection includes positive findings on clinical examination, imaging, or 
laboratory tests (e.g., white blood cells in a normally sterile body fluid, 
perforated viscus, and chest radiograph consistent with pneumonia, petechial 
or purpuric rash, or purpura fulminans). 
Sepsis 
SIRS in the presence of or as a result of suspected or proven infection. 
 
 
 
 Severe sepsis 
Sepsis plus one of the following: cardiovascular organ dysfunction 
OR acute respiratory distress syndrome or two or more other organ 
dysfunctions.  
Septic shock 
Sepsis and cardiovascular organ dysfunction. 
Cardiovascular dysfunction 
Despite administration of isotonic intravenous fluid bolus of greater 
than 40 ml/kg in 1 hour.   
Decrease in BP (hypotension) < 5th percentile for age or 
Systolic BP > 2 SD below normal for age (a) OR 
Need for vasoactive drug to maintain BP in normal range 
(Dopamine> 5 mcg/kg/min or dobutamine, epinephrine, or 
Norepinephrine at any dose) OR Two of the following 
Unexplained metabolic acidosis: base deficit > 5.0 meq/l 
Increased arterial lactate > 2 times upper limit of normal 
Oliguria: urine output < 0.5 ml/kg/hr 
Prolonged capillary refill: > 5 secs 
Core to peripheral temperature gap > 3°C 
 
 Dysfunction of Respiratory System (b) 
PaO2/FIO2< 300 in absence of cyanotic heart disease or 
Pre-existing lung disease OR 
PaCO2> 65 torr or 20 mm Hg over baseline PaCO2 OR 
Proven need (c) or > 50% FIO2 to maintain saturation > 92% OR 
          Need for non elective invasive or non-invasive mechanical ventilation (d). 
Neurologic dysfunction 
Glasgow coma score < 11 OR 
Acute change in mental status with a decrease in Glasgow 
Coma score > 3 points from abnormal baseline 
Dysfunction of haematological system 
Platelet count < 80,000/mm
3
 or a drop in platelet count of 50% from 
highest value recorded over the past 3 days (for chronic haematology 
/oncology patients) OR 
International normalized ratio > 2 
Renal dysfunction 
Serum creatinine > 2 times upper limit of normal for age or 2 fold 
increase in baseline creatinine 
 
 
 Hepatic dysfunction 
Total bilirubin > 4 mg/dL (not applicable for new-born) OR 
Serum alanine transaminase 2 times upper limit of normal for age 
MODS (Multi Organ Dysfunction)   
Presence of two or more organ dysfunction. 
 (a) See Table (I); 
Table (I) 
Age - Specific vital signs and laboratory values
* 
Age group 
 
Heart rate  
 
Tachycardia  Bradycardia                      
Respiratory 
rate 
Breaths/min 
 
Leukocyte 
count 
x1000/cu.mm 
 
SBP 
 
 
0-1 >180                   <100 >50 
 
> 34 
<65 
1 Week to 1 
month 
>180                  <100 >40 
 
>19.5 or  <5 
<75 
1 month to 1 year >180                  <90 
 
>34 
>17.5 or  <5 <100 
2 - 5 years >140                  NA >22 >15.5 or  <6 <94 
6 - 12 years >130                  NA >18 
>13.5 or  
<4.5 
<105 
13 - 18 years >110                  NA >14 >11or <4.5 <117 
 
*
Lower values  for  heart rate, leukocyte count, systolic blood pressure (SBP) are for the 
5
th
 percentile and upper values for heart rate, respiratory rate, or leukocycte count for the 
95
th
 percentile. NA – Not Applicable 
 
(b) Acute respiratory distress syndrome must include acute onset, new onset 
of bilateral infiltrates on CXR, PaO2/ FIO2 ratio < 200 mm Hg, and no 
 evidence of left heart failure. Acute lung injury is defined similarly except 
thePaO2/FIO2 ratio must be < 300 mm Hg; 
(c) Proven need assumes oxygen requirement was tested by decreasing flow 
with subsequent increase in flow if required;  
(d) In postoperative patients, this requirement can be met if the patient has 
developed an acute inflammatory or infectious process in the lungs that 
prevents him or her from being extubated. 
WHO criteria for Anemia: 
6 months to 5 years - < 11g/dl 
5 to 12 years - < 11.5g/dl 
Under nutrition: 
 Determined by WHO criteria
40
. Z - score cut off point < -2 standard 
deviation is under nutrition.   
Serum sodium: 135 to 145 meq/l; Serum potassium: 3.5 to 5.5meq/l 
Arterial lactate: 4.5 to 14.4 mg/dl (0.5-1.6 mmol/l)
41 
MANEUVER: 
Children between 3 months to 12 years admitted with clinical 
diagnosis of septic shock were included. Clinical diagnosis of septic shock 
was made based on pediatric assessment triangle – temperature instability 
with warm or cold shock or hypotensive shock
42
.  
 Following clinical data were recorded in proforma after obtaining 
consent from the parents–age, sex, clinical history, examination findings, 
duration of stay, Treatment after admission in PICU, vital parameters, 
complete blood count, peripheral smear, blood culture, urine analysis, urine 
culture, blood urea, serum electrolytes, serum creatinine, serum bilirubin, 
serum alanine transaminase, Blood gas analysis was obtained in all cases. 
Prothrombin time, activated partial thromboplastin time was measured if 
clinically indicated. CSF analysis was done in children with clinical 
suspicion of CNS infection.  
Lactate in arterial blood was measured at 0 to 3 hours and after 24 
hours of admission. Lactate level was estimated using enzymatic method at 
the Lister laboratories, Coimbatore. Cobos E400 colorimeter was used for 
measurement. The principle is lactate oxidase catalyses the oxidation of 
lactate to pyruvate and hydrogen peroxide. Peroxidase then catalyses the 
reaction of hydrogen peroxide with a hydrogen donor, in the presence of 4 
aminophenazone to form a dye. Color intensity, measured at 550 nm, is 
proportional to lactate concentration in the sample. 
 
 
 
 RESULTS 
STATISTICAL ANALYSIS: 
Data were analyzed using SPSS software version 17 and MedCalc 
software version 15. Data were interpreted using descriptive and inferential 
statistics. The Chi-square test was used to test the statistical significance of 
relationship between two variables. Student T test was used to determine if 
there is a significant difference between the mean of two groups. The cut off 
value was estimated by using Receiver Operating Characteristics Curve 
(ROC) analysis
43
. Area under the ROC curve more than 0.5 indicates that the 
test predicts outcome better than no chance. Optimum cut off values were 
determined using associated criterion. The curve represents graphical 
relationship between sensitivity and 1 -specificity. Odds ratio is calculated 
from measure of association between exposure and outcome. 
 
Screening test results 
Outcome 
Poor                             Good 
 
Total 
Positive a (True positive)    b (False positive) a + b 
Negative a (False positive)    d (True negative) c + d 
 
PPV- Positive Predictive value   = [a / (a + b)] x 100 
NPV- Negative Predictive value   =   [d / (c + d)] x 100 
 AGE DISTRIBUTION OF STUDY POPULATION 
 
TABLE 1 
 
Age Frequency Percent 
3 months - 12 months 26 47.3% 
13 months - 60 months 21 38.2% 
61 months - 144 months 8 14.5% 
Total 55 100% 
 
                              CHART   1 
 
 
Out of 55 children studied,  26 (47.3%) children were between 3 
month and 1 year. 21 children (38.2%) were between 1 and 5 years. 8 
children (14.5%) were between 5 and 12 years 
 
 
 
47%
38%
15%
AGE
3 months - 12 months 13 months - 60 months
61 months - 144 months
  
 
 
 
 
Among the study population, 30 were male children and 25 were 
female children. 
 
 
 
 
 
 
 
 
GENDER 
TABLE 2 
 
       CHART 2 
55%
45%
GENDER
Male Female
Sex Frequency Percent 
Male 30 54.5% 
Female 25 45.5% 
Total 55 100% 
 
 DIAGONSIS 
 
TABLE 3 
 
Diagnosis Frequency Percent 
Urosepsis 3 5.5% 
Bronchopneumonia 36 65.5% 
Acute Diarrhoeal Disease 8 14.5% 
Liver Abscess 1 1.8% 
Meningitis 7 12.7% 
Total 55 100% 
 
 
CHART 3 
 
 
 
 
 
 
 
Urosepsis
5%
Bronchopn
eumonia
65%
ADD
15%
Liver 
Abscess
2%
Meningitis
13%
DIAGNOSIS
 ANEMIA 
 
TABLE 4 
 
Anemia Frequency Percent 
Not Present 17 30.9% 
Present 38 69.1% 
Total 55 100% 
 
 
CHART 4 
 
 
 
Among 55 children admitted in the PICU in the study period, anemia 
was observed 38 (69.1%) cases. 
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ANEMIA
 UNDER NUTRITION 
 
TABLE 5 
 
Under nutrition Frequency Percent 
Not Present 15 27.3% 
Present 40 72.7% 
Total 55 100% 
 
 
CHART 5 
 
 
Among the study population, under nutrition was present in 40 
(72.7%) cases. 
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UNDER NUTRITION
 VENTILATION REQUIREMENT: 
 
TABLE 6 
 
Ventilation Frequency Percent 
Not Required 28 50.9% 
Required 27 49.1% 
Total 55 100% 
 
 
CHART 6 
 
Among the study population, ventilation was required in 27 (49.1%) 
cases. 
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VENTILATION
 ORGAN DYSFUNCTION 
 
TABLE 7 
 
Organ dysfunction Frequency Percent 
Not present 19 34.5% 
Present 36 65.5% 
Total 55 100% 
 
 
CHART 7 
 
 
In the study population, organ dysfunction was observed in 36 
(65.5%) cases. 
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ORGAN DYSFUNCTION
 OUTCOME: 
 
TABLE 8 
 
Outcome Frequency Percent 
Survivors 31 56.4% 
Non Survivors 24 43.6% 
Total 55 100% 
 
 
 
CHART 8 
 
 
Among the study population, survivors were 31 (56.4%) cases and 
non survivors were 24(43.6%) cases. 
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OUTCOME
 LACTATE AT (0 TO 3) HOURS VS OUTCOME 
 
TABLE 9 
 
  OUTCOME 
LACTATE AT  
0-3 hrs 
Survivors Non-Survivors 
20.1 – 30.0 19(95.0 %) 1(5 .0%) 
30.1 – 40.0 7(100.0 %) - 
40.1 – 50.0 3(33.3 %) 6(66.7 %) 
50.1 – 60.0 1(20.0 %) 4(80.0 %) 
60.1 – 70.0 1(10.0 % ) 9(90.0%) 
70.1 – 80.0 - 4(100.0 %) 
 
The Chi square value is 36.2; p value < 0.001. There is a significant 
association between lactate level (0 – 3 hours) and outcome. From the table 
it can be inferred that with increase in lactate level, the number of non 
survivors increase. Above the cut off value of ≥ 41mg/dl (from ROC 
analysis) number of non survivors are 23. Lactate level greater than 70 
mg/dl, had 100% mortality.   
 
 
 
 
 
 
 
 
 
 
 
 
 LACTATE AT 24 HOURS VS OUTCOME 
 
TABLE 10 
 
 OUTCOME 
LACTATE 
AFTER 24 hrs 
Survivors Non-Survivors 
10.1 – 20.0 13(92.9 %) 1(7.1 %) 
20.1 – 30.0 14(100.0 %) - 
30.1 – 40.0 1(33.3 %) 2(66.7 %) 
40.1 – 50.0 2(25.0 %) 6(75.0%) 
50.1 – 60.0 - 7(100.0%) 
60.1 – 70.0 1(12.5%) 7(87.5%) 
70.1 – 80.0 - 1(100 %) 
 
 
The Chi Square value is 40.2; p value is < 0.001. There is a 
significant association between lactate level 24hours and outcome. From the 
table it can be inferred that with increase in lactate level, the number of non 
survivors increase. Above the cut off value of ≥ 39.2 mg/dl (from ROC 
analysis) number of non survivors are 21.  
 
 
 
 
 
 
 
 
 
 
 LACTATE AT 0 TO 3 HOURS VS OUTCOME 
 
TABLE 11 
 
 
Outcome N Mean 
Std. 
Deviation 
Lactate at 0 
to 3hrs 
Survivor 31 32.316 10.7871 
Non 
Survivor 
24 58.471 11.4228 
 
Independent Samples Test  
 F0 T Df Sig  
Lactate at 0 to    Equal  variances assumed           
3hrs                    Equal variance not assumed  
.483 8.69 53 .000 
 
 
T value for mean difference in initial lactate level between survivors 
and non survivors is significant (p<0.001).the mean lactate level among 
survivors and non survivors was 32.3mg/dl and 58.4mg /dl respectively. It 
can be inferred that initial lactate level is significantly high in non survivors 
compared with survivors 
 
 
 
 
 
 
 
 
 LACTATE AT 24 HOURS VS OUTCOME 
 
TABLE 12 
 
Outcome N Mean 
Std. 
Deviation 
Lactate at 24 
hrs after 
admission 
Survivor 31 24.729 10.3953 
Non 
Survivor 
24 53.283 12.2881 
 
 
Independent Samples Test  
 F0 T df Sig  
Lactate at 24 hrs Equal variances assumed 
after admission    
                            Equal variance not assumed  
1.73 9.33 53 .000 
 
The T value (9.33) for mean difference in lactate level measured at 24 
hours between survivors and non survivors is significant (p<0.001).the mean 
lactate level among survivors and non survivors was 24.7mg/dl and 53.2 mg 
/dl respectively. It can be inferred that lactate level at 24 hours is 
significantly high in non survivors compared with survivors. 
          
 
 
 
 
 
 
 
 
 AGE VS OUTCOME 
 
TABLE 13 
 
 
AGE 
OUTCOME 
SURVIVORS % NON SURVIVORS % 
3 months – 12 months 16 61.5 10 38.5 
13 months – 60 months 10 47.6 11 52.4 
61 months – 144 months 5 62.5 3 37.5 
 
  Non survivors were high (52.4%) in age group 13 to 60 months. The 
Chi square value is 1.058 for the association between age and outcome 
which is not statistically significant (p=0.58). It can be inferred that there is 
no association between age and outcome. 
 
ANEMIA VS OUTCOME 
 
TABLE 14 
 
 
ANEMIA 
OUTCOME 
SURVIVORS % NON SURVIVORS % 
Present 22 57.9 16 42.1 
Not Present 9 52.9 8 47.1 
 
Among children with anemia, survivors were 22 (57.9%) and non 
survivors were 16 (42.15). The Chi square value 0.117 for the association 
between anemia and outcome are not statistically significant (p = 0.732). It 
 can be inferred that there is no association between presence of anemia and 
outcome. 
DIAGNOSIS VS OUTCOME 
 
TABLE 15 
 
 
DIAGNOSIS 
OUTCOME 
SURVIVORS % NON 
SURVIVORS 
% 
Urosepsis 3 100.0 - - 
Bronchopneumonia 18 50.0 18 50.0 
Acute diarrhoeal disease 6 75.0 2 25.0 
Liver  Abscess 1 100.0 - - 
Meningitis 3 42.9 4 57.1 
 
Among children with bronchopneumonia mortality was 50%. In 
children with meningitis mortality was 57.1%. The Chi square value 5.338 
for the association between diagnosis and outcome is not statistically 
significant (p=0.254). It can be inferred that there is no association between 
diagnosis and outcome. 
 
 
 
 
 
 UNDER NUTRITION VS OUTCOME 
TABLE 16 
 
 
UNDER NURTRITION 
OUTCOME 
SURVIVORS % NON 
SURVIVORS 
% 
Present 19 47.5 21 52.5 
Not Present 12 80.0 3 20.0 
 
52.5% children with under nutrition expired. The Chi square value 
4.685 for the association between undernutrition and outcome is statistically 
significant (p=0.030). It can be inferred that there is association between 
presence of undernutrition and outcome. 
 
REQUIRED VENTILATION VS OUTCOME 
 
TABLE 17 
 
 
VENTILATION 
OUTCOME 
SURVIVORS % NON 
SURVIVORS 
% 
Required 9 33.3 18 66.7 
Not Required 18 78.6 6 21.4 
 
Need for ventilation was present in 18 non survivors. The Chi square 
value 11.43 for the association between requirement of ventilation and 
 outcome is statistically significant (p=0.001). It can be inferred that there is 
association between requirement of ventilation and outcome. 
 
ORGAN DYSFUNCTION VS OUTCOME 
 
TABLE 18 
 
 
ORGAN 
DYSFUNCTION 
OUTCOME 
SURVIVOR % NON 
SURVIVOR 
% 
Present 14 38.9 22 61.1 
Not Present 17 89.5 2 10.5 
 
Oxygen dysfunction, was present in 61.1% of non survivors. The Chi 
square value 12.939 for the association between presence of organ 
dysfunction and outcome is significant (p=0.001). It can be inferred that 
there is association between presence of organ dysfunction and outcome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 RECEIVER OPERATING CHARACTERISTICS CURVE ANALYSIS 
 
TABLE 19 
 
Variable Lactate at 0 to 3 hrs  
Sample size 55 
Positive 
group 
OUTCOME =1 31 
Negative 
group 
OUTCOME = 0 24 
 
 
Area under the ROC Curve 
 
Area under the ROC curve ( AUC ) 0.935 
Standard  Error 0.0347 
95 % Confidence interval 0.834 to 0.984 
Z statistic 12.519 
Significance level P(Area =0.5 ) < 0.0001 
Associated Criterion ≥ 41 
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 Criterion values and coordinates of the ROC curve 
 
Crite
rion 
Sensitivity 95 % CI Specificit
y 
Criterio
n 
Sensitivit
y 
95 % CI Specif
icity 
≥21 0 0.0 - 11.2 100 ≥43.4 87.1 70.2 - 96.4 87.5 
≥21 6.45 0.8 - 21.4 100 ≥45.7 87.1 70.2 - 96.4 83.33 
≥22.8 9.68 2.0 - 25.8 100 ≥48.4 90.32 74.2 - 98.0 83.33 
≥23 12.9 3.6 - 29.8 100 ≥49.8 93.55 78.6 - 99.2 70.83 
≥24.8 16.13 5.5 - 33.7 100 ≥51 93.55 78.6 - 99.2 66.67 
≥25.6 22.58 9.6 - 41.1 100 ≥55.6 96.77 83.3 - 99.9 62.5 
≥25.8 29.03 14.2 - 48.0 100 ≥57.8 96.77 83.3 - 99.9 58.33 
≥26.2 32.26 16.7 - 51.4 100 ≥58.8 96.77 83.3 - 99.9 54.17 
≥26.4 35.48 19.2 - 54.6 100 ≥60.2 96.77 83.3 - 99.9 50 
≥26.8 38.71 21.8 - 57.8 100 ≥60.9 96.77 83.3 - 99.9 45.83 
≥27.4 41.94 24.5 - 60.9 100 ≥62.4 96.77 83.3 - 99.9 41.67 
≥28.2 45.16 27.3 - 64.0 100 ≥63.2 96.77 83.3 - 99.9 37.5 
≥28.6 51.61 33.1 - 69.8 100 ≥64.2 96.77 83.3 - 99.9 33.33 
≥28.7 51.61 33.1 - 69.8 95.83 ≥64.6 96.77 83.3 - 99.9 29.17 
≥28.8 54.84 36.0 - 72.7 95.83 ≥66.2 96.77 83.3 - 99.9 25 
≥29 58.06 39.1 - 75.5 95.83 ≥68 96.77 83.3 - 99.9 20.83 
≥29.8 61.29 42.2 - 78.2 95.83 ≥68.8 100 88.8 - 
100.0 
16.67 
≥31 64.52 45.4 - 80.8 95.83 ≥70.2 100 88.8 - 
100.0 
12.5 
≥31.2 67.74 48.6 - 83.3 95.83 ≥72.4 100 88.8 - 
100.0 
4.17 
≥32.4 70.97 52.0 - 85.8 95.83 ≥76 100 88.8 - 
100.0 
0 
≥33.8 74.19 55.4 - 88.1 95.83     
≥37.2 77.42 58.9 - 90.4 95.83     
≥38 80.65 62.5 - 92.5 95.83     
≥39.4 83.87 66.3 - 94.5 95.83     
≥41 87.1 70.2 - 96.4 95.83     
 
The area under ROC curve for lactate measured at 0 to 3 hours is 
0.935 which is statistically significant. The optimum cut off value for lactate 
at 0 to 3 hours as observed from receiver operating characteristics curve is ≥ 
41 mg /dl (4.55 mmol/ L). The sensitivity was 87.1% and specificity was 
95.8% 
 TABLE 20 
Variable LACTATE at 24 Hours  
Sample size 55 
Positive group OUTCOME =1 31 
Negative group OUTCOME = 0 24 
 
 
Area under the ROC Curve 
 
Area under the ROC curve ( AUC ) 0.926 
Standard  Error 0.0431 
95 % Confidence interval 0.823 to 0.979 
Z statistic 9.874 
Significance level P(Area =0.5 ) <0.0001 
Associated criterion ≥39.2 
 
 
 
 
 
 
 
 
 
 
 
 
LACTATE_2
0 20 40 60 80 100
0
20
40
60
80
100
100-Specificity
S
e
n
s
it
iv
it
y
 Criterion values and coordinates of the ROC curve 
 
Criterion Sensitivity 95 % CI Specificity Criterion Sensitivity 95 % CI Specificity 
≥16 0 0.0 - 11.2 100 ≥39.6 90.32 74.2 - 98.0 87.5 
≥16 6.45 0.8 - 21.4 100 ≥40.6 90.32 74.2 - 98.0 83.33 
≥16.4 9.68 2.0 - 25.8 100 ≥45.2 93.55 78.6 - 99.2 75 
≥16.6 12.9 3.6 - 29.8 100 ≥45.6 93.55 78.6 - 99.2 70.83 
≥17.4 12.9 3.6 - 29.8 95.83 ≥46.6 93.55 78.6 - 99.2 66.67 
≥18.2 16.13 5.5 - 33.7 95.83 ≥49.8 96.77 83.3 - 99.9 62.5 
≥18.6 22.58 9.6 - 41.1 95.83 ≥51 96.77 83.3 - 99.9 58.33 
≥18.8 29.03 14.2 - 48.0 95.83 ≥51.4 96.77 83.3 - 99.9 54.17 
≥19.2 35.48 19.2 - 54.6 95.83 ≥52.8 96.77 83.3 - 99.9 50 
≥19.8 38.71 21.8 - 57.8 95.83 ≥54.6 96.77 83.3 - 99.9 45.83 
≥20 41.94 24.5 - 60.9 95.83 ≥58.4 96.77 83.3 - 99.9 41.67 
≥20.6 45.16 27.3 - 64.0 95.83 ≥58.8 96.77 83.3 - 99.9 37.5 
≥21 51.61 33.1 - 69.8 95.83 ≥59.4 96.77 83.3 - 99.9 33.33 
≥22 58.06 39.1 - 75.5 95.83 ≥60.2 96.77 83.3 - 99.9 29.17 
≥23 61.29 42.2 - 78.2 95.83 ≥61 100 88.8 - 100.0 25 
≥23.4 64.52 45.4 - 80.8 95.83 ≥61.2 100 88.8 - 100.0 20.83 
≥24.6 70.97 52.0 - 85.8 95.83 ≥64.4 100 88.8 - 100.0 16.67 
≥25.2 74.19 55.4 - 88.1 95.83 ≥66 100 88.8 - 100.0 12.5 
≥26.2 77.42 58.9 - 90.4 95.83 ≥68.8 100 88.8 - 100.0 8.33 
≥26.8 80.65 62.5 - 92.5 95.83 ≥69.4 100 88.8 - 100.0 4.17 
≥27.2 83.87 66.3 - 94.5 95.83 ≥71.8 100 88.8 - 100.0 0 
≥39.2 90.32 74.2 - 98.0 95.83     
 
 
 The area under ROC curve for lactate measured at 24 hours is 0.926 
which is statistically significant. The optimum cut off value for lactate at 24 
hours as observed from receiver operating characteristics curve is ≥ 39.2 mg 
/dl (4.35 mmol/l). The sensitivity was 90.3% and specificity was 95.8%. 
 
 
 
 
 
 
 
 
 
 TABLE 21 
Lactate Cut-off value 
Odds 
ratio 
PPV NPV P-Value 
0 to 3 hours ≥ 41 mg/dl 119.6 82.1  % 96.2 % <0.0001 
24 hours after ≥ 39.2 mg /dl 65.33 85.1 % 96.4 % <0.0001 
 
The odds ratio, positive predictive value and negative predictive value 
for the cut off value of lactate ≥ 41 mg/dl measured at 0 to 3 hours are 119.6, 
82.1% and 96.2% respectively. These were statistically significant. 
The odds ratio, positive predictive value for the cut off value of lactate 
≥ 39.2 mg/dl measured at 24 hours are 65.33, 85.1% and 96.4% respectively. 
These were statistically significant. 
 
 
 
 
 
 
 
 
 
 DISCUSSION 
The total number of children with septic shock admitted during the 
study period were 55 in number. Among them 30 were boys and 25 were 
girls.  Anemia was observed in 38 cases. Undernutrition was observed in 40 
cases.  There were 31 survivors and 24 non survivors. Mortality was 43.6%. 
Bronchopneumonia (65.5%) was the most cause of septic shock in our 
study followed by acute diarrhoeal disease (14.5%), meningitis (12.7%), 
urosepsis (5.5%). This is comparable to study by Kolski et al in which 
bronchopneumonia was the common infection. This is also comparable to 
study by Kana Ram Jat et al in which bronchopneumonia accounted for 
73.3% cases. Mortality in our study was 43.6%. This is comparable to 
observations by Kana Ram Jat et al. Mortality was 50% in their study. In 
children with urosepsis, E coli was the causative organism. 
Organ dysfunction other than cardiovascular dysfunction was 
observed in 36(65.5%) cases. This is comparable to study by Kana Ram Jat 
et al in which organ dysfunction was observed in 66.7% of cases. 
Respiratory dysfunction (50%) was the most common next to cardiovascular 
organ system dysfunction. 
From ROC analysis, the optimal cut off value for lactate measured at 
0 to 3 hours was ≥ 41 mg/dl (4.55 mmol/l). For lactate measured at 24 hours, 
 the optimal cut off value was ≥ 39.2 mg/dl (4.35 mmol/l). Both initial and 
lactate at 24 hours were significantly high in non survivors (p<0.001). The 
association between lactate measured at 0 to 3 hours and outcome was 
significant. Also there was significant association between lactate measured 
at 24 hours and outcome. Initial lactate level of >41 mg/dl had sensitivity of 
87% and specificity of 95.8%. Lactate level at 24 hours had sensitivity of 
90% and specificity of 95.8%.  High lactate level,  presence of organ 
dysfunction and under nutrition were independently associated with poor 
outcome.  
In our study , initial lactate level of  ≥ 41mg/dl ( 4.55 mmol/l) and 24 
hours lactate level of  ≥ 39.2 mg/dl (4.35 mmol / l) was significantly 
associated with poor outcome .This is comparable  to previous study 
conducted by Kana Ram Jat et al
23
 in which lactate ≥ 5 mmol/l or 45 mg/dl 
was significantly associated with poor outcome .In contrast to our study, 
Duke et al
26
 reported lactate level of  ≥ 3 mmol/l  was a significant predictor 
of outcome. But in the study conducted by Duke et al
26
, children with sepsis 
were the study population. Barat Ramakrishna et al studied children with 
pneumonia and reported a cut off  > 2mmol/l. 
         Age, sex and presence of anemia were not significantly different between non 
survivors and survivors. Presence of undernutrition and organ dysfunction were 
significantly associated with death. 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY 
• Out of 55 children included in the study, boy children were 30, girl children 
were 25. 47.3 % of children were under age of 1 year, 38.2 % were between 
1 and 5 years, 14.5 % of children were between 5 and 12 years  
• Pneumonia (65.5 %) was the most common cause for septic shock 
• Anemia was observed in 69.1 % of cases and undernutrition was observed 
in72.7% of cases 
• Organ dysfunction other than  cardiovascular dysfunction was observed in 
36 ( 65.5% ) children of which respiratory dysfunction was observed in 18 
cases 
• Mortality in our study was 43.6% out of 55 children with septic shock, 31 
children were survivors and 24 children were non survivors.  
• Non survivors were high in 13 – 60 months age group. 
• Lactate  measured at 0 to 3 hours and at 24 hours was significantly high in 
non survivors 
• Apart from serum lactate, presence of organ dysfunction and under nutrition 
were significantly associated with poor outcome. 
• Initial serum lactate value  ≥ 41 mg/dl ( 4.55 mmol /L ) and serum lactate 
value of  ≥ 39.2  mg /dl (4.35 mmol /l ) at 24 hours were significant 
predictors of poor outcome in children with septic shock. 
 CONCLUSION 
Septic shock is a common cause for mortality and morbidity in children. 
Early recognition and goal directed therapy is necessary to prevent complications. 
Our study demonstrated high serum lactate was associated with higher 
mortality. Serial determination of serum lactate levels was a better predictor of poor 
outcome. 
. 
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 PROFORMA: 
 
NAME: 
 
AGE: 
 
SEX: 
 
PLACE: 
 
 
 
 
PRESENTING COMPLAINTS: 
 
  Cough & Cold 
  Fever 
  Difficulty In Breathing 
  Loose Stools 
  Vomiting 
  Urine Output 
  Convulsions 
  Altered Sensorium 
 
 
EXAMINATION:  
APPEARANCE   
BREATHING 
COLOUR 
AIRWAY  
RESPIRATORY RATE  
TIDAL VOLUME 
WOB 
AIR ENTRY 
ADDED SOUNDS  
SPO2 
HEART RATE 
PULSE VOLUME 
 CRT 
TEMP .GAP  
BP  
LIVER SPAN 
URINE (hr)  
AVPU  
DEM 
PERL 
FIT / BLEEDING 
INTERVENTION 
GENERAL EXAMINATION 
 
Anemia 
Jaundice 
Clubbing 
Cyanosis 
Pedal Edema 
Lymphadenopathy 
Nutrition 
 
SYSTEMIC EXAMINATION : 
CVS : 
 
 
RS : 
 
 
ABDOMEN : 
 
 
CNS: 
 
INVESTIGATIONS: 
Complete Blood Count 
 Total count  
  Hb –  
Platelet Count  ---- 
  Dc : N ____ L _____ 
Blood Urea : 
Blood Sugar :  
Serum Creatinine : 
Serum Sodium : 
Serum Potassium : 
Serrum Bilirublin 
SGOT,SGPT 
PT,APTT,INR 
Serum  Lactate  :               Less Than 3 Hrs                                24  Hrs 
 
CRP: 
ESR 
ABG 
 Blood C/S : 
 Urine   C/S : 
 Urine  Routine : 
CXR: 
CSF Analysis 
 
TREATMENT GIVEN: 
 
 
OUTCOME: 
 
 
 Name  Age Sex Diagnosis Count Na+ K+ Anemia 
Under 
Nutrition Ventilation 
Organ 
Dysfunction 
Lact (0 
-3 hr) 
Lac 
(After 
24 hrs Outcome 
Valasalal 
rahman     
3 months - 
12 months Male UTI 17500 136 4.2 
Not 
Present Present 
Not 
Required Not present 39.4 23 Survivor 
Karuppasamy         
3 months - 
12 months Male Bronchopneumonia 16500 137 5 Present Present Required Present 60.2 58.4 Non_Survivor 
Hemavarshini        
3 months - 
12 months Female Meningitis 15000 143 4.4 
Not 
Present Present Required Present 57.8 51 Non_Survivor 
Dharsan              
3 months - 
12 months Male UTI 10500 132 3.5 Present 
Not 
Present 
Not 
Required Not present 32.4 27.6 Survivor 
Nithish              
13 months - 
60 months Male Bronchopneumonia 13000 139 3.8 Present Present Required Present 26.2 18.8 Survivor 
Keerthana            
13 months - 
60 months Female Liver Abscess 31000 132 4.6 
Not 
Present Present 
Not 
Required Not present 24.8 16.6 Survivor 
Rajim                
3 months - 
12 months Female Bronchopneumonia 18000 134 5.2 Present Present Required Present 60.9 54.6 Non_Survivor 
Salmon parvish      
3 months - 
12 months Male Meningitis 10900 140 4.2 Present Present 
Not 
Required Present 31 23.4 Survivor 
Santhoshkumar       
13 months - 
60 months Male Bronchopneumonia 16800 136 3.8 Present 
Not 
Present 
Not 
Required Not present 41 24.6 Survivor 
Rithika              
13 months - 
60 months Female Bronchopneumonia 12500 139 3.5 
Not 
Present Present Required Present 25.8 16 Survivor 
Kishori              
3 months - 
12 months Female Bronchopneumonia 15600 140 3.6 Present Present 
Not 
Required Not present 27.4 18.8 Survivor 
Halubuisha           
13 months - 
60 months Female Bronchopneumonia 9900 137 4.2 Present Present Required Present 29 21 Survivor 
Shrikh Arsadh       
13 months - 
60 months Male Meningitis 13500 138 4.8 
Not 
Present Present 
Not 
Required Present 38 25.2 Survivor 
Sridar               
13 months - 
60 months Male Bronchopneumonia 18000 143 5 Present Present Required Present 64.6 52.8 Non_Survivor 
Krishna 
moorthy      
3 months - 
12 months Male Bronchopneumonia 9800 138 3.6 
Not 
Present 
Not 
Present 
Not 
Required Not present 25.8 16 Survivor 
Darika               13 months - Female Bronchopneumonia 7500 144 4.6 Present Present Not Present 26.4 19.8 Survivor 
 60 months Required 
Basila               
13 months - 
60 months Female Bronchopneumonia 16000 144 3.8 Present Present Required Present 72.4 66 Non_Survivor 
Swathika             
3 months - 
12 months Female ADD 15600 143 3.2 Present 
Not 
Present 
Not 
Required Not present 33.8 27.2 Survivor 
Santhosh             
3 months - 
12 months Male ADD 7800 141 2.8 Present Present Required Present 29.8 26.2 Survivor 
Nithyarubini         
13 months - 
60 months Female Bronchopneumonia 8800 138 3.5 Present Present 
Not 
Required Not present 22.8 16.4 Survivor 
Narmatha             
3 months - 
12 months Female Bronchopneumonia 28000 135 3.8 
Not 
Present 
Not 
Present 
Not 
Required Not present 37.2 26.8 Survivor 
Logesh               
3 months - 
12 months Male ADD 16000 137 4 Present Present 
Not 
Required Present 25.6 19.2 Survivor 
Sriragavan           
3 months - 
12 months Male Bronchopneumonia 14300 144 3.6 Present Present Required Present 26.8 20.6 Survivor 
Aslin                
61 months - 
144 months Female Meningitis 19000 142 4.4 Present Present 
Not 
Required Present 76 71.8 Non_Survivor 
Kathirvel            
3 months - 
12 months Male Bronchopneumonia 15600 138 3.8 
Not 
Present 
Not 
Present Required Present 28.8 20 Survivor 
Imisha               
3 months - 
12 months Female Bronchopneumonia 16000 140 3.4 Present Present Required Present 43.4 39.6 Non_Survivor 
Adithyamathi        
3 months - 
12 months Female Bronchopneumonia 16500 138 4.2 Present Present 
Not 
Required Not present 28.6 22 Survivor 
Prem                 
3 months - 
12 months Male Bronchopneumonia 15800 143 4.4 Present Present Required Present 55.6 49.8 Non_Survivor 
Babu                 
3 months - 
12 months Male Bronchopneumonia 14200 144 3.8 Present 
Not 
Present Required Present 62.4 60.2 Non_Survivor 
Kavya                
13 months - 
60 months Female Bronchopneumonia 22000 137 4.2 
Not 
Present Present Required Present 49.8 45.2 Non_Survivor 
Abirami              
3 months - 
12 months Female Bronchopneumonia 8900 142 3.8 Present 
Not 
Present 
Not 
Required Present 25.6 19.2 Survivor 
Siva                 
3 months - 
12 months Male Bronchopneumonia 15300 144 3.5 Present Present Required Present 58.8 51.4 Non_Survivor 
Devika               61 months - Female ADD 17000 140 3 Present Present Not Not present 64.2 58.8 Non_Survivor 
 144 months Required 
Suresh               
13 months - 
60 months Male Bronchopneumonia 13900 135 3.8 
Not 
Present Present Required Present 49.8 46.6 Non_Survivor 
Poorani              
3 months - 
12 months Female Bronchopneumonia 14300 138 4.2 Present 
Not 
Present Required Present 68 61.2 Non_Survivor 
Kannamma            
13 months - 
60 months Female Bronchopneumonia 13800 140 3.5 Present Present Required Present 63.2 59.4 Non_Survivor 
Mahesh               
3 months - 
12 months Male ADD 8100 140 2.6 Present 
Not 
Present 
Not 
Required Not present 28.2 21 Survivor 
Arun                 
13 months - 
60 months Male Meningitis 19100 135 4 
Not 
Present Present Required Present 49.8 45.2 Non_Survivor 
Roopa                
3 months - 
12 months Female Bronchopneumonia 10200 136 5 Present Present 
Not 
Required Not present 21 18.6 Survivor 
Parvathi             
13 months - 
60 months Female Bronchopneumonia 14300 137 4.2 
Not 
Present Present Required Present 68.8 61 Non_Survivor 
Raja                 
13 months - 
60 months Male UTI 7900 139 4.8 
Not 
Present 
Not 
Present 
Not 
Required Not present 23 18.2 Survivor 
Kumar                
13 months - 
60 months Male Bronchopneumonia 15600 142 3.8 Present Present Required Present 51 45.6 Non_Survivor 
Selvambal            
3 months - 
12 months Female Meningitis 16700 139 3.6 Present Present Required Present 66.2 64.4 Non_Survivor 
Pravin               
61 months - 
144 months Male Bronchopneumonia 10500 135 4 Present Present 
Not 
Required Not present 31.2 24.6 Survivor 
Kannan               
3 months - 
12 months Male ADD 18800 136 3.4 
Not 
Present Present 
Not 
Required Present 70.2 69.4 Non_Survivor 
Deepak               
13 months - 
60 months Male Bronchopneumonia 13500 140 4.8 Present 
Not 
Present Required Present 72.4 68.8 Non_Survivor 
Devi                 
61 months - 
144 months Female Bronchopneumonia 12000 138 4 Present Present 
Not 
Required Not present 48.4 39.2 Survivor 
Priya                
13 months - 
60 months Female Bronchopneumonia 13900 135 4 
Not 
Present Present 
Not 
Required Present 43.4 39.6 Non_Survivor 
Naveen               
13 months - 
60 months Male ADD 22000 142 3.6 Present 
Not 
Present 
Not 
Required Not present 28.6 22 Survivor 
Senthil              61 months - Male Meningitis 16700 137 4.2 Present Not Required Present 55.6 49.8 Survivor 
 144 months Present 
Murugan              
13 months - 
60 months Male Bronchopneumonia 13800 136 4 
Not 
Present Present 
Not 
Required Present 45.7 40.6 Non_Survivor 
shanmugam           
61 months - 
144 months Male Bronchopneumonia 16000 138 4.6 Present Present 
Not 
Required Not present 28.7 17.4 Non_Survivor 
Fathima              
61 months - 
144 months Female Bronchopneumonia 16500 141 3.8 Present Present 
Not 
Required Not present 49.8 45.2 Survivor 
sudalai              
61 months - 
144 months Male Bronchopneumonia 7900 135 3.8 
Not 
Present Present Required Present 21 18.6 Survivor 
Pogal                
3 months - 
12 months Male ADD 13900 138 4.2 Present 
Not 
Present Required Present 68.8 61 Survivor 
OBJECTIVES OF THE STUDY 
1.  To determine the association between serum lactate level and mortality in 
pediatric septic shock. 
2.  To determine whether serial determination of serum lactate level is a 
predictor of outcome in pediatric septic shock. 
3.   To determine the association between organ dysfunction, presence of 
anemia, malnutrition, diagnosis and outcome in pediatric septic shock. 
 
MATERIAL AND METHODS : 
50 Children between 3 months to 12 years admitted with clinical diagnosis 
of septic shock were included. Clinical diagnosis of septic shock was made based 
on pediatric assessment triangle – temperature instability with warm or cold shock 
or hypotensive shock.  Following clinical data were recorded in proforma after 
obtaining consent from the parents–age, sex, clinical history, examination findings, 
duration of stay, Treatment after admission in PICU, vital parameters, complete 
blood count, peripheral smear, blood culture, urine analysis, urine culture, blood 
urea, serum electrolytes, serum creatinine, serum bilirubin, serum alanine 
transaminase, Blood gas analysis was obtained in all cases. Prothrombin time, 
activated partial thromboplastin time was measured if clinically indicated. CSF 
analysis was done in children with clinical suspicion of CNS infection.  Lactate in 
arterial blood was measured at 0 to 3 hours and after 24 hours of admission. 
Lactate level was estimated using enzymatic method. 
RESULTS 
The odds ratio, positive predictive value and negative predictive value for 
the cut off value of lactate ≥ 41 mg/dl measured at 0 to 3 hours are 119.6, 82.1% 
and 96.2% respectively. These were statistically significant.  The odds ratio, 
positive predictive value for the cut off value of lactate ≥ 39.2 mg/dl measured at 
24 hours are 65.33, 85.1% and 96.4% respectively. These were statistically 
significant. 
 
• Lactate  measured at 0 to 3 hours and at 24 hours was significantly high in non 
survivors.  Apart from serum lactate, presence of organ dysfunction and under 
nutrition were significantly associated with poor outcome. 
• Initial serum lactate value  ≥ 41 mg/dl ( 4.55 mmol /L ) and serum lactate value of  
≥ 39.2  mg /dl (4.35 mmol /l ) at 24 hours were significant predictors of poor 
outcome in children with septic shock. 
 
